Literature DB >> 26024673

Failed glaucoma drainage implant: long-term outcomes of a second glaucoma drainage device versus cyclophotocoagulation.

Jamie Lea Schaefer1, Monica A Levine2, Gina Martorana2, Helen Koenigsman2, M Fran Smith2, Mark B Sherwood2.   

Abstract

BACKGROUND/AIMS: To evaluate long-term efficacy of a second glaucoma drainage device (GDD) versus cyclophotocoagulation (CPC) after failure of primary drainage implant.
METHODS: This is a non-randomised, retrospective cohort study. A chart review was conducted of patients who underwent GDD surgery between July 1986 and November 2012 requiring further glaucoma procedures for intraocular pressure (IOP) control. An additional GDD was placed in 15 eyes, while 32 eyes underwent CPC. The main outcome measurement was IOP control and/or time to failure of secondary intervention (IOP >18 mm Hg on two sequential measurements).
RESULTS: Mean follow-up after the second procedure was 63±65.8 months (range 6-254 months) in the CPC group and 132±91.8 months (range 12-254 months) in the GDD group. Thirty-four per cent (11/32 eyes) undergoing CPC later required further treatment at a mean of 13.6±10.7 months with 10/11(91%) of additional interventions occurring within 2 years. Despite an initially high success rate for IOP control in the first 5 years, eventually 60% (9/15 eyes) that underwent a second tube required additional treatment at a mean of 73.4 months with only 2/9(22%) requiring this within the first 2 years. The risk of visual acuity worsening by 2 Snellen lines or more at 12 months was 5/14 for the GDD group (36%) and 4/23(17%) for the CPC group.
CONCLUSIONS: After failure of an initial drainage implant to control IOP, a sequential tube had a high initial rate of success but a relatively high likelihood of long-term failure, generally after 6 years. Eyes that received CPC tended to fail earlier, often within the first year, but had relatively few late failures. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Glaucoma; Intraocular pressure; Treatment Lasers; Treatment Surgery

Mesh:

Year:  2015        PMID: 26024673     DOI: 10.1136/bjophthalmol-2015-306725

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

Review 1.  [Revision surgery in episcleral glaucoma drainage devices].

Authors:  A Rosentreter; T S Dietlein
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

2.  Gold shunt for refractory advanced low-tension glaucoma with spared central acuity.

Authors:  Ryan Le; Neeru Gupta
Journal:  Int Med Case Rep J       Date:  2016-03-18

3.  Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma.

Authors:  Chiara Posarelli; Mario Damiano Toro; Robert Rejdak; Tomasz Żarnowski; Dorota Pożarowska; Antonio Longo; Mario Miccoli; Marco Nardi; Michele Figus
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

Review 4.  Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options.

Authors:  Anna I Dastiridou; Andreas Katsanos; Philippe Denis; Brian A Francis; Dimitrios G Mikropoulos; Miguel A Teus; Anastasios-Georgios Konstas
Journal:  Adv Ther       Date:  2018-11-17       Impact factor: 3.845

5.  Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation.

Authors:  Markus Lenzhofer; Melchior Hohensinn; Wolfgang Hitzl; Veit Steiner; Armin Motaabbed; Karolina Motloch; Hans Peter Colvin; Herbert A Reitsamer; Sarah Moussa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-02       Impact factor: 3.117

6.  Comparison of Outcomes Following Glaucoma Drainage Tube Surgery Between Primary and Secondary Glaucomas, and Between Phakic and Pseudophakic eyes.

Authors:  Emily F Dawson; Brady E Culpepper; Charlotte A Bolch; Phuong T Nguyen; Alissa M Meyer; Cooper D Rodgers; Mary Kate Wilson; Ryan J Smith; Nicole C Rosenberg; C Richard Blake; Mark B Sherwood
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-11-24

7.  Outcomes of Baerveldt Glaucoma Drainage Devices in Pediatric Eyes.

Authors:  Adam Jacobson; Cagri G Besirli; Brenda L Bohnsack
Journal:  J Glaucoma       Date:  2021-12-21       Impact factor: 2.290

8.  Outcomes of the Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation Treatment Study: A Randomized Comparative Trial.

Authors:  Robert M Feldman; Alice Z Chuang; Steve L Mansberger; Angelo P Tanna; Lauren S Blieden; Nicholas P Bell; Ronald L Gross; Louis R Pasquale; David S Greenfield; Jeffrey M Liebmann; Robert N Weinreb
Journal:  J Glaucoma       Date:  2022-07-21       Impact factor: 2.290

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.